Ritu Roy

8PUBLICATIONS
51CO-AUTHORS
Molecular targetsCancer geneticsPredictive and prognostic markersMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 01, 2026
Dynamic genetic and nongenetic RAS pathway activation drives resistance to FLT3 and BCL2 inhibitor therapy.

|Mar 27, 2025
Impact of BRCA mutations, age, surgical indication, and hormone status on the molecular phenotype of the human Fallopian tube.

Ian Beddows, Svetlana Djirackor, Dalia K Omran

|Sep 26, 2024
Self-reported cancer-related cognitive impairment is associated with perturbed neurotransmission pathways.

Kate R Oppegaard, Yvette P Conley, Steven Paul

|Sep 18, 2024
Multiomic single cell sequencing identifies stemlike nature of mixed phenotype acute leukemia.

Cheryl A C Peretz, Vanessa E Kennedy, Anushka Walia

|Apr 27, 2024
Neurodegenerative disease pathways are perturbed in patients with cancer who self-report cognitive changes and anxiety: A pathway impact analysis.

Kate R Oppegaard, Samantha J Mayo, Terri S Armstrong

|Apr 11, 2023
Prediction of morning fatigue severity in outpatients receiving chemotherapy: less may still be more.

Kord M Kober, Ritu Roy, Yvette Conley

Pageof 2

Frequent Collaborators

4 joint publications

Christine Miaskowski

4 joint publications

Yvette P Conley

4 joint publications

Kord M Kober

3 joint publications

Jon Levine